Arterial Hypertension
Pulmonary Arterial Hypertension
Myocardial Ischemia
Heart Failure
Blood loss
Parkinson’s Disease (PD)
Stroke
Brain Blood Barrier Passage
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Ulcer
Emesis & Nausea
Gastric Emptying
Intestinal Transit
Type 1 diabetes
Type 2 diabetes
Asthma
COPD
Cough
As an innovative preclinical CRO with relevant disease models we offer robust drug efficacy data and high value interpretation to assist drug discovery companies in evaluating the potential of their therapeutic compounds.
DISEASE MODELS
CUSTOMERS
TECHNICAL DATA SHEETS
As you know Syncrosome is involved in in vivo Preclinical activities since 17 years and we offer robust and well-validated models to our customer to t...
29 septembre, 2017 Syncrosome NewsOur Scientific Manager, Sandra Robelet, will launch a talk on the new preclinical strategy combining in vitro and in vivo models to assess the drug ef...
26 septembre, 2017 Central Nervous SystemSyncrosome invites you to visit us at Nutrevent, June 14th to 15th 2017, in Lille, France. Emmanuelle Bettendorf, our Business Developer would ...
13 juin, 2017 Syncrosome NewsUlcerative Colitis is a chronic and relapsing inflammatory disease. Inflammation plays a major part in the symptoms of this disease that is characteri...
31 mai, 2017 Gastroenterology
